COVID-19 / Coronavirus

AnPac Bio-Medical Science Enters into Asset Purchase Agreement with Easy Hundred Inc.

2023-04-03 21:00 2668

NEW YORK, April 3, 2023 /PRNewswire/ -- AnPac Bio-Medical Science Co., Ltd. (the "Company") (NASDAQ: ANPC), a company with operations inthe United States andChina focused on early cancer screening and detection and entering into the operation of a business-to-business e-commerce food platform foc...

The World's Second Approved Biosimilars of Denosumab (MAILISHU)

2023-04-03 13:44 1763

SHANGHAI, April 3, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with the layout of whole industry chain, announced that the Denosumab solution for injection (trade name: MAILISHU, project code: 9MW0311), which is developed by its wholly-owned subsidiary T-m...

Fosun International Holds 2022 Annual Results Announcement. Guo Guangchang: Realizing Sustainable and Rapid Development in 2023

2023-03-31 15:27 3188

HONG KONG, March 31, 2023 /PRNewswire/ -- "Despite how difficult in 2022, the past is behind us. We should focus on 2023 and the future. Despite how much hardship entrepreneurs have endured, we never dwell on the past. We are always thinking ahead and advancing." On the morning of 30 March, Fosu...

Yunkang Group Announces First Annual Results Since Listing

2023-03-31 13:05 3402

Revenue increases by 121.4% to RMB 3,756 million Profit attributable to owners of the Company of RMB 377 million Three major businesses grow rapidly through in-depth service and lean management  HONG KONG, March 31, 2023 /PRNewswire/ -- Yunkang Group Limited ("Yunkang" or the "Group"; Stock Cod...

Everest Medicines Announces Financial Results for Full Year Ended December 31, 2022

2023-03-31 07:30 3606

SHANGHAI, March 31, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing, manufacturing and commercializing transformative pharmaceutical products and vaccines, today announced its financial results for the full year...

Kintor Pharma Announces 2022 Annual Results and Recent Business Progress

2023-03-31 00:33 2938

SUZHOU, China, March 30, 2023 /PRNewswire/ -- Kintor Pharmaceutical Limited (Kintor Pharma, HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today announced business highlights and financial results for the year ended31 Decembe...

Viva Biotech Announced 2022 Annual Results:

2023-03-31 00:25 3437

Revenue and Gross Profit with Steady Growth Competitive Advantages of One-stop Platform Continuously Demonstrating Financial highlights of the year ended December 31, 2022: * Revenue amounted to RMB2,379.6 million, representing a year-on-year (YoY) increase of 13.1% * Gross profit amounted to...

Zhongchao Inc. Announces Launch of Health Education Intelligent Content Production Platform

2023-03-30 20:00 1521

SHANGHAI, March 30, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services to patients with cancer and other major diseases, today announced the launch of "E-Class," medical education intelligent content p...

Great Place To Work unveils Best Workplaces in the Inaugural Singapore Healthcare and Biopharma List 2023

2023-03-30 12:00 2229

Employees express trust in leaders' competence and integrity and value fairness and impartiality as part of the workplace culture SINGAPORE, March 30, 2023 /PRNewswire/ -- Great Place To Work®, the global authority on workplace culture announced the 10 companies who are Best WorkplacesTM in its ...

Broncus Medical (02216.HK) Announces Annual Results for 2022

2023-03-30 01:05 3062

Product sales in China for 2022 increased 50% compared to the same period in 2021, while product development and commercialization are steadily advancing. HANGZHOU, China, March 30, 2023 /PRNewswire/ -- On March 29, 2023, Broncus Medical (02216.HK), a leader in precise interventional diagnosis an...

Scivita Medical enters into Strategic Agreement with Boston Scientific in China

2023-03-29 21:08 1441

SUZHOU, China, March 29, 2023 /PRNewswire/ -- Medical technology company Scivita Medical Technology Co., Ltd. ('Scivita Medical') and Boston Scientific (NYSE: BSX), one of the leading medical technology companies worldwide, have officially signed aStrategic Agreement for Scivita's Single-Use Perc...

Fosun Pharma Announces its 15th Corporate Social Responsibility Report: Continuous Innovation for the Benefit of the Public

2023-03-29 14:06 1591

SHANGHAI, March 29, 2023 /PRNewswire/ -- On March 27, 2023, the release date of its 2022 Annual Report, Fosun Pharma (stock code: 600196.SH; 02196.HK) also released the2022 Corporate Social Responsibility Report, its 15th CSR report since the first which was issued in 2009. As before, Fosun Pharm...

Kintor Pharma Announces Completion of Subject Enrollment in Phase III Clinical Trial of KX-826 for Treatment of Male Androgenetic Alopecia in China

2023-03-28 21:41 1430

SUZHOU, China, March 28, 2023 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, announced that the company has completed the enrollment of 740 subjects recently for...

Seegene declares to share Syndromic PCR technologies to prevent future pandemics

2023-03-28 19:00 1646

* Localization of Seegene Syndromic PCR technologies with global partners for versatile and proactive response to local emerging healthcare demands. * Formation of a collaborative global network to aggressively develop innovative syndromic PCR assays, challenging boundaries of PCR application....

BD and A*STAR collaborate to Advance Ultra-High Dimensional Analysis in Flow Cytometry for Immunology Research

2023-03-28 14:12 1686

SINGAPORE, March 28, 2023 /PRNewswire/ -- Becton Dickinson Holdings Pte Ltd (BD), a global leader in life science technologies, and the Agency for Science, Technology and Research (A*STAR),Singapore's lead public sector R&D agency, have announced an extended research partnership that will focus o...

Boan Biotech Announces 2022 Financial Results

2023-03-27 23:15 3086

Showing accelerated innovation and strong 225% revenue growth YANTAI, China, March 27, 2023 /PRNewswire/ -- Boan Biotech (6955.HK) today announced its 2022 financial results and recent business developments. 2022 business highlights * Record high in revenue: In 2022, Boan Biotech's revenue was...

Aramco to expand presence in China by acquiring 10% stake in Rongsheng Petrochemical

2023-03-27 23:10 2333

- Deal involves placement of 480,000 barrels per day of crude to the largest integrated refining and chemicals complex inChina DHAHRAN, Saudi Arabia, March 27, 2023 /PRNewswire/ -- Aramco, one of the world's leading integrated energy and chemicals companies, has signed definitive agreements to ...

CGTN: How China keeps its promise to build a community of common health for mankind

2023-03-27 21:43 2052

BEIJING, March 27, 2023 /PRNewswire/ -- Recognizing China for its support during the pandemic, the Senate of theDominican Republic recently presented China with an award. The Senate's Vice President Santiago Zorrilla said at the award ceremony that theDominican Republic will always remember China...

Aramco JV HAPCO to commence construction of major refinery and petrochemical complex in China

2023-03-27 20:32 1907

* Greenfield project to include 300,000 bpd refinery and 1.65 million tons steam cracker * Aramco to supply up to 210,000 barrels per day of crude oil feedstock to the project * Integrated refining and petrochemical complex expected to be fully operational by 2026 * Complex to be located ...

YS Biopharma's PIKA Recombinant COVID-19 Vaccine Demonstrates Superior Antibody Neutralization Responses Compared to Inactivated COVID-19 Vaccine in Phase II Head-to-Head Clinical Study

2023-03-27 18:00 1667

* The trial met its primary endpoint of superior immunogenicity of PIKA COVID-19 Vaccine vs inactivated COVID-19 vaccine, measured by GMT of neutralizing antibody against Omicron virus on Day 14, with statistical significance (95%CI: 2.1, 3.4, P<0.0001) based on interim data analysis * The tr...

1 ... 12131415161718 ... 226

Week's Top Stories